Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3773548
Title:
ACTIVITÉ ANTITUMORALE IN VITRO ET DE XÉNOGREFFE D'UN XANTHÈNE HALOGÉNÉ CONTRE DES TUMEURS SOLIDES PÉDIATRIQUES RÉFRACTAIRES
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
198043267
WO application number:
US2019032435
Type:
European patent granted for BE
Status:
Open
Publication number:
3773548
WO publication number:
WO2019222361
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
15/05/2019
Grant date:
09/08/2023
EP publication date:
17/02/2021
WO publication date:
21/11/2019
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
09/08/2023
EP B1 publication date:
09/08/2023
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
15/05/2039
Applicant
1
Name:
Provectus Pharmatech, Inc.
Legal Form:
From:
09/08/2023
Address:
10025 Investment Drive, Suite 250, Knoxville, Tennessee 37932, United States (US)
To:
2
Name:
The Governors of the University of Calgary
Legal Form:
From:
09/08/2023
Address:
2500 University Drive NW, Calgary, Alberta T2N 1N4, Canada (CA)
To:
Agent
Name:
KIRKPATRICK
Legal Form:
From:
08/11/2023
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)